← Tüm fırsatlar

TÜBİTAK · Türkiye

EP PerMed 2027 — Cell and Gene Therapies for Personalised Medicine (Turkey participation)

Açık

Başvurular 20 Ocak 2027 tarihinde kapanıyor.

Not: international consortium and national application required.

Program özeti

The 2027 joint call supports development and validation of innovative cell and gene therapies for personalised human medicine. Approaches include somatic-cell therapies, gene therapies, combined cell/gene therapies and specified biological products. Proposals are submitted by multinational consortia through a two-stage international process.

Kimler başvurabilir

Participating Turkish researchers must also submit a national application to TÜBİTAK. The national route uses programme 1071; consortium and national eligibility rules both apply.

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Zamanlama

International short proposal: 20 January 2027, 14:00 CET. National submissions and later stages have separate deadlines; consult the official call timetable.

Nasıl başvurulur

1. Check consortium composition, scientific scope and national eligibility.
2. Coordinate the international short proposal before 20 January 2027, 14:00 CET.
3. Complete the separate TÜBİTAK national application and any later stages on their own schedules.

From the call text

Who can apply

Not stated in the call text we hold — check the official page

Company stage

Not stated in the call text we hold — check the official page

Single applicant or consortium

The national route uses programme 1071; consortium and national eligibility rules both apply.

Where applicants must be based

Not stated in the call text we hold — check the official page

Where to apply

Not stated in the call text we hold — check the official page

Resmi kaynaklar

Resmi çağrı sayfası

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 11 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.

TÜBİTAK: diğer çağrılar